Cargando…
The effect of oral probiotics on CD4 count in patients with HIV infection undergoing treatment with ART who have had an immunological failure
INTRODUCTION: Probiotics are live microorganisms that, when administered in appropriate colonies, can delay the destruction of the immune system and contribute to the maintenance of immunity in HIV patients. Probiotics play an important role in stimulating natural killer T cells, strengthening the f...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266137/ https://www.ncbi.nlm.nih.gov/pubmed/37382253 http://dx.doi.org/10.1002/iid3.913 |
_version_ | 1785058682168410112 |
---|---|
author | Mortezazadeh, Masoud Kalantari, Saeed Abolghasemi, Nooshin Ranjbar, Mitra Ebrahimi, Saeedeh Mofidi, Abbas Pezeshkpour, Babak Mansouri, Ensieh Sadat Tabatabaei, Seyed Zia Kashani, Mehdi |
author_facet | Mortezazadeh, Masoud Kalantari, Saeed Abolghasemi, Nooshin Ranjbar, Mitra Ebrahimi, Saeedeh Mofidi, Abbas Pezeshkpour, Babak Mansouri, Ensieh Sadat Tabatabaei, Seyed Zia Kashani, Mehdi |
author_sort | Mortezazadeh, Masoud |
collection | PubMed |
description | INTRODUCTION: Probiotics are live microorganisms that, when administered in appropriate colonies, can delay the destruction of the immune system and contribute to the maintenance of immunity in HIV patients. Probiotics play an important role in stimulating natural killer T cells, strengthening the functional gut barrier, and reducing systemic inflammation. METHODS: This study was a randomized double‐blind clinical trial involving 30 patients treated with antiretroviral therapy who had experienced immunological failure despite HIV viral suppression. Patients were divided into two equal groups of 15, group (B) received two probiotic capsules daily with a colony count of 10⁹ CFU per capsule containing seven strains, after 3 months they were examined for CD4(+) counts by flow cytometry, and after a 1‐month washout period the participants who had received probiotics were switched to placebo, and the participants who had received placebo were given probiotics for 3 months, and they were examined for CD4(+) counts 7 months after the start of the study. RESULTS: In the first group (A), administration of the placebo resulted in a decrease in CD4 count in the first 3 months (from 202.21 to 181.79, p value < .001), which may be due to the natural history of the disease. After probiotics administration, CD4 count increased significantly (from 181.79 to 243.86, p value < .001). Overall, after 7 months of study, there was a significant increase in the mean CD count from 202.21 to 243.86 (p value < .001). In the second group (B), the administration of probiotics in the first 3 months of the study resulted in a significant increase in the mean CD4 count (from 126.45 to 175.73, p value < .001). Termination of treatment with probiotics resulted in a significant decrease (from 175.73 to 138.9, p value < .001) but overall the CD4 count at the end of the study was significantly higher than at baseline (p value < .001). |
format | Online Article Text |
id | pubmed-10266137 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-102661372023-06-15 The effect of oral probiotics on CD4 count in patients with HIV infection undergoing treatment with ART who have had an immunological failure Mortezazadeh, Masoud Kalantari, Saeed Abolghasemi, Nooshin Ranjbar, Mitra Ebrahimi, Saeedeh Mofidi, Abbas Pezeshkpour, Babak Mansouri, Ensieh Sadat Tabatabaei, Seyed Zia Kashani, Mehdi Immun Inflamm Dis Original Articles INTRODUCTION: Probiotics are live microorganisms that, when administered in appropriate colonies, can delay the destruction of the immune system and contribute to the maintenance of immunity in HIV patients. Probiotics play an important role in stimulating natural killer T cells, strengthening the functional gut barrier, and reducing systemic inflammation. METHODS: This study was a randomized double‐blind clinical trial involving 30 patients treated with antiretroviral therapy who had experienced immunological failure despite HIV viral suppression. Patients were divided into two equal groups of 15, group (B) received two probiotic capsules daily with a colony count of 10⁹ CFU per capsule containing seven strains, after 3 months they were examined for CD4(+) counts by flow cytometry, and after a 1‐month washout period the participants who had received probiotics were switched to placebo, and the participants who had received placebo were given probiotics for 3 months, and they were examined for CD4(+) counts 7 months after the start of the study. RESULTS: In the first group (A), administration of the placebo resulted in a decrease in CD4 count in the first 3 months (from 202.21 to 181.79, p value < .001), which may be due to the natural history of the disease. After probiotics administration, CD4 count increased significantly (from 181.79 to 243.86, p value < .001). Overall, after 7 months of study, there was a significant increase in the mean CD count from 202.21 to 243.86 (p value < .001). In the second group (B), the administration of probiotics in the first 3 months of the study resulted in a significant increase in the mean CD4 count (from 126.45 to 175.73, p value < .001). Termination of treatment with probiotics resulted in a significant decrease (from 175.73 to 138.9, p value < .001) but overall the CD4 count at the end of the study was significantly higher than at baseline (p value < .001). John Wiley and Sons Inc. 2023-06-14 /pmc/articles/PMC10266137/ /pubmed/37382253 http://dx.doi.org/10.1002/iid3.913 Text en © 2023 The Authors. Immunity, Inflammation and Disease published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Mortezazadeh, Masoud Kalantari, Saeed Abolghasemi, Nooshin Ranjbar, Mitra Ebrahimi, Saeedeh Mofidi, Abbas Pezeshkpour, Babak Mansouri, Ensieh Sadat Tabatabaei, Seyed Zia Kashani, Mehdi The effect of oral probiotics on CD4 count in patients with HIV infection undergoing treatment with ART who have had an immunological failure |
title | The effect of oral probiotics on CD4 count in patients with HIV infection undergoing treatment with ART who have had an immunological failure |
title_full | The effect of oral probiotics on CD4 count in patients with HIV infection undergoing treatment with ART who have had an immunological failure |
title_fullStr | The effect of oral probiotics on CD4 count in patients with HIV infection undergoing treatment with ART who have had an immunological failure |
title_full_unstemmed | The effect of oral probiotics on CD4 count in patients with HIV infection undergoing treatment with ART who have had an immunological failure |
title_short | The effect of oral probiotics on CD4 count in patients with HIV infection undergoing treatment with ART who have had an immunological failure |
title_sort | effect of oral probiotics on cd4 count in patients with hiv infection undergoing treatment with art who have had an immunological failure |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266137/ https://www.ncbi.nlm.nih.gov/pubmed/37382253 http://dx.doi.org/10.1002/iid3.913 |
work_keys_str_mv | AT mortezazadehmasoud theeffectoforalprobioticsoncd4countinpatientswithhivinfectionundergoingtreatmentwithartwhohavehadanimmunologicalfailure AT kalantarisaeed theeffectoforalprobioticsoncd4countinpatientswithhivinfectionundergoingtreatmentwithartwhohavehadanimmunologicalfailure AT abolghaseminooshin theeffectoforalprobioticsoncd4countinpatientswithhivinfectionundergoingtreatmentwithartwhohavehadanimmunologicalfailure AT ranjbarmitra theeffectoforalprobioticsoncd4countinpatientswithhivinfectionundergoingtreatmentwithartwhohavehadanimmunologicalfailure AT ebrahimisaeedeh theeffectoforalprobioticsoncd4countinpatientswithhivinfectionundergoingtreatmentwithartwhohavehadanimmunologicalfailure AT mofidiabbas theeffectoforalprobioticsoncd4countinpatientswithhivinfectionundergoingtreatmentwithartwhohavehadanimmunologicalfailure AT pezeshkpourbabak theeffectoforalprobioticsoncd4countinpatientswithhivinfectionundergoingtreatmentwithartwhohavehadanimmunologicalfailure AT mansouriensiehsadat theeffectoforalprobioticsoncd4countinpatientswithhivinfectionundergoingtreatmentwithartwhohavehadanimmunologicalfailure AT tabatabaeiseyedzia theeffectoforalprobioticsoncd4countinpatientswithhivinfectionundergoingtreatmentwithartwhohavehadanimmunologicalfailure AT kashanimehdi theeffectoforalprobioticsoncd4countinpatientswithhivinfectionundergoingtreatmentwithartwhohavehadanimmunologicalfailure AT mortezazadehmasoud effectoforalprobioticsoncd4countinpatientswithhivinfectionundergoingtreatmentwithartwhohavehadanimmunologicalfailure AT kalantarisaeed effectoforalprobioticsoncd4countinpatientswithhivinfectionundergoingtreatmentwithartwhohavehadanimmunologicalfailure AT abolghaseminooshin effectoforalprobioticsoncd4countinpatientswithhivinfectionundergoingtreatmentwithartwhohavehadanimmunologicalfailure AT ranjbarmitra effectoforalprobioticsoncd4countinpatientswithhivinfectionundergoingtreatmentwithartwhohavehadanimmunologicalfailure AT ebrahimisaeedeh effectoforalprobioticsoncd4countinpatientswithhivinfectionundergoingtreatmentwithartwhohavehadanimmunologicalfailure AT mofidiabbas effectoforalprobioticsoncd4countinpatientswithhivinfectionundergoingtreatmentwithartwhohavehadanimmunologicalfailure AT pezeshkpourbabak effectoforalprobioticsoncd4countinpatientswithhivinfectionundergoingtreatmentwithartwhohavehadanimmunologicalfailure AT mansouriensiehsadat effectoforalprobioticsoncd4countinpatientswithhivinfectionundergoingtreatmentwithartwhohavehadanimmunologicalfailure AT tabatabaeiseyedzia effectoforalprobioticsoncd4countinpatientswithhivinfectionundergoingtreatmentwithartwhohavehadanimmunologicalfailure AT kashanimehdi effectoforalprobioticsoncd4countinpatientswithhivinfectionundergoingtreatmentwithartwhohavehadanimmunologicalfailure |